化疗
癌症
癌症研究
免疫疗法
脂质代谢
药品
脂肪酸代谢
医学
抗药性
生物
药理学
新陈代谢
内科学
微生物学
作者
Jiale Qin,Lvlan Ye,Xiangqiong Wen,Xiang Zhang,Yuqin Di,Zhihui Chen,Ziyang Wang
出处
期刊:Cancer Letters
[Elsevier BV]
日期:2023-08-18
卷期号:572: 216352-216352
被引量:44
标识
DOI:10.1016/j.canlet.2023.216352
摘要
Despite the remarkable clinical success of immunotherapy and molecular targeted therapy in patients with advanced tumors, chemotherapy remains the most commonly used treatment for most tumor patients. Chemotherapy drugs effectively inhibit tumor cell proliferation and survival through their remarkable mechanisms. However, tumor cells often develop severe intrinsic and acquired chemoresistance under chemotherapy stress, limiting the effectiveness of chemotherapy and leading to treatment failure. Growing evidence suggests that alterations in lipid metabolism may be implicated in the development of chemoresistance in tumors. Therefore, in this review, we provide a comprehensive overview of fatty acid metabolism and its impact on chemoresistance mechanisms. Additionally, we discuss the potential of targeting fatty acid metabolism as a therapeutic strategy to overcome drug resistance.
科研通智能强力驱动
Strongly Powered by AbleSci AI